Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
16.94 AUD | +0.36% | +2.23% | +5.15% |
Mar. 28 | Australia's Armaguard secures funding from parent, rejects rescue deal | RE |
Mar. 08 | Recce Pharmaceuticals Secures AU$11.2 Million R&D Advance; Shares Up 5% | MT |
Sales 2024 * | 43.54B 28.34B | Sales 2025 * | 44.56B 29B | Capitalization | 22.58B 14.7B |
---|---|---|---|---|---|
Net income 2024 * | 1.06B 691M | Net income 2025 * | 1.12B 726M | EV / Sales 2024 * | 0.72 x |
Net Debt 2024 * | 8.85B 5.76B | Net Debt 2025 * | 9.09B 5.92B | EV / Sales 2025 * | 0.71 x |
P/E ratio 2024 * |
21.3
x | P/E ratio 2025 * |
20.3
x | Employees | 120,000 |
Yield 2024 * |
3.91% | Yield 2025 * |
4.1% | Free-Float | 99.4% |
Latest transcript on Coles Group Limited
1 day | +0.36% | ||
1 week | +2.23% | ||
Current month | +0.24% | ||
1 month | +1.50% | ||
3 months | +5.28% | ||
6 months | +8.59% | ||
Current year | +5.15% |
Managers | Title | Age | Since |
---|---|---|---|
Leah Weckert
CEO | Chief Executive Officer | - | 10-12-31 |
Charlie Elias
DFI | Director of Finance/CFO | - | 22-02-27 |
John Cox
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
James Graham
CHM | Chairman | 75 | 18-11-18 |
Andrew Penn
BRD | Director/Board Member | 61 | Nov. 30 |
Scott Price
BRD | Director/Board Member | 63 | 22-09-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
2.18% | 120 M€ | +3.38% | - | |
0.89% | 144 M€ | +4.93% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 16.94 | +0.36% | 2,941,689 |
24-03-27 | 16.88 | +1.56% | 2,756,912 |
24-03-26 | 16.62 | +0.48% | 2,100,097 |
24-03-25 | 16.54 | +0.30% | 1,914,332 |
24-03-22 | 16.49 | -0.48% | 4,411,890 |
Delayed Quote Australian S.E., March 28, 2024 at 01:10 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+5.15% | 14.73B | |
-2.43% | 41.87B | |
+18.28% | 38.22B | |
+10.85% | 35.32B | |
+11.47% | 21.13B | |
-20.23% | 12.48B | |
-4.17% | 11.85B | |
-.--% | 11.82B | |
+15.91% | 11.79B | |
-15.85% | 9.54B |